GO
Loading...

Enter multiple symbols separated by commas

Stocks Pfizer Inc

More

  • Britain raps Pfizer over inflated drug prices Thursday, 6 Aug 2015 | 7:10 AM ET
    Pfizer

    Britain's competition watchdog alleged that U.S. drugmaker Pfizer and Flynn Pharma had breached competition law.

  • CVS will no longer cover Viagra Wednesday, 5 Aug 2015 | 7:55 PM ET
    Viagra pills on display.

    Discount retail chain CVS will no longer include Pfizer's Viagra in its list of drug insurance benefits, CNBC confirmed on Wednesday.

  • Aug 5- CVS Health Corp, which operates the nation's second-biggest pharmacy benefit manager, said that next year it will exclude an additional 31 prescription medicines from insurance coverage, including Viagra and widely used treatments for diabetes and multiple sclerosis. The 2016 excluded drugs, disclosed on Wednesday, also include Vivus Inc's weight...

  • Aug 5- CVS Health Corp, which operates the nation's second-biggest pharmacy benefit manager, said that next year it will exclude an additional 31 prescription medicines from insurance coverage, including Viagra and widely used treatments for diabetes and multiple sclerosis. The 2016 excluded drugs, disclosed on Wednesday, also include Vivus Inc's weight...

  • Are we seeing a new dawn of innovation in pharma? Wednesday, 5 Aug 2015 | 1:50 AM ET
    Modernizing Medicine's electronic medical assistant.

    Innovation has always been the blood pumping through the body of the pharma industry, but in recent years the supply seemed to be getting poorer.

  • Hospira headquarters

    The federal government says health care facilities should stop using Hospira's Symbiq medication infusion pump because its vulnerable to hacking.

  • Your first trade for Monday Friday, 31 Jul 2015 | 5:54 PM ET

    The "Fast Money" traders give their final trades of the day.

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed lower on the final day of trade for July, as investors digested energy earnings misses and soft data that could delay liftoff.

  • Top 5 stocks of the week and how to trade them Friday, 31 Jul 2015 | 3:06 PM ET
    Pfizer

    CNBC Pro highlights the top performing stocks this week and analyzes whether the good times will continue.

  • UK's AstraZeneca beats profit forecasts Thursday, 30 Jul 2015 | 3:05 AM ET
    Viagra made by Pfizer and Nexium made by AstraZeneca.

    AstraZeneca revenue fell by a smaller-than-expected 7 percent in the second quarter.

  • LONDON, July 30- AstraZeneca revenue fell by a smaller-than-expected 7 percent in the second quarter, as income from spinning off assets offset generic competition to older medicines and a strong dollar. Chief Executive Pascal Soriot, who fended off a $118 billion takeover attempt by Pfizer last year, is banking on a promising pipeline of new drugs-...

  • July 29- Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, on Wednesday said the cost of potent, newly approved cholesterol drugs could "wreak financial havoc" among its clients. Express Scripts, which administers drug benefits for employers and health plans and also runs large mail-order pharmacies, has been challenging...

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed higher after the Fed kept rates unchanged and the continued recovery in oil prices encouraged investor sentiment.

  • July 29- Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, on Wednesday said the cost of potent new cholesterol drugs called PCSK9 inhibitors could "wreak financial havoc" among its clients. U.S. regulators on Friday approved the first of the new medicines, Praluent from Regeneron Pharmaceuticals Inc and Sanofi SA.

  • Pharma earnings were a 'mixed bag': Expert Tuesday, 28 Jul 2015 | 8:22 PM ET
    Pharma earnings were a 'mixed bag': Expert

    Raghuram Selvaraju, managing director for equity research healthcare division at MLV & Co, discusses the quarterly results of pharmaceutical giants such as Pfizer and Merck & Co.

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed about 1 percent higher as investors cheered some recovery in oil prices, amid mixed earnings and the beginning of the Fed meeting.

  • *Baidu slumps after results miss expectations. China's top securities regulator said on Monday that Beijing would keep buying shares to stabilize the market, after the steepest decline in Chinese stocks in eight years. Baidu slumped as much as 17.7 percent to $162.72 after China's biggest Internet search company's quarterly profit missed estimates.

  • Options traders bet against Pfizer Tuesday, 28 Jul 2015 | 12:04 PM ET
    People walk past Pfizer world headquarters in New York City.

    Before Pfizer's earnings beat, traders placed bearish bets for a big drop in the next month.

  • *Baidu slumps after results miss expectations. *Pfizer, Ford rise after results. Wall Street sank on Monday, for the fifth straight day, after the steepest decline in Chinese stocks in eight years increased concerns about slowing growth in the country.

  • Early movers: F, PFE, MRK, DD, WYN, DHI & more Tuesday, 28 Jul 2015 | 8:36 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.